<DOC>
	<DOCNO>NCT00596791</DOCNO>
	<brief_summary>The purpose study investigate change ocular sign symptom occur patient ocular hypertension glaucoma switch latanoprost 0.005 % ( Xalatan ) preservative free Tafluprost eye drop .</brief_summary>
	<brief_title>Ocular Signs Symptoms Glaucoma Patients Switched From Latanoprost 0.005 % Preservative Free Tafluprost Eye Drops</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Signs Symptoms</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Patients diagnosis ocular hypertension open angle glaucoma patient use latanoprost 0.005 % his/her prior medication . Evaluable patient must ocular surface relate symptom and/or sign prior medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>